Effects of black seed (Nigella Sativa) on type 2 cytokines gene expression and mucus production in the airways of asthmatic mice
Archives of Medical Laboratory Sciences,
Vol. 2 No. 2 (2016),
16 Shahrivar 2016
https://doi.org/10.22037/amls.v2i2.14527
Abstract
Background: Black Seed (BS) is used in traditional medicine as a therapy for a variety of diseases including allergic asthma.
Materials and Methods: In the present study, anti-inflammatory and immunomodulatory effects of BS on cytokine gene expression, lung airway eosinophilia and goblet cell hyperplasia were examined in a mouse mice model of allergic asthma. Groups of 6-week-old female BALB/c mice were sensitized by intraperitoneal injections of OVA plus alum on days 1 and 14. On days 24, 26, 28 and 30, the mice were exposed to OVA in saline for 30 min with nebulizer. Similar experiments were conducted with mice receiving saline as a negative control.
Results: The mouse allergic asthma model received BS by food on days 23, 25, 27 and 29. Then, the percentage of inflammatory cells as well as mRNA expression levels of interleukin (IL)-4, IL-5, IL-13 and mucin (MUC5a) genes were survived in Broncho-alveolar lavage fluid (BALF). Furthermore, we attempted to examine histopathological examination of the lung. Mice receiving BS showed a significant decrease in the number of eosinophils, and a potential inhibitory effect on mRNA expression levels of Th2-driven immune response cytokines and mucin, resulting in decreased production of interleukin and mucin in allergic asthma.
Conclusion: Our findings suggested that BS has an anti-inflammatory and immunomodulatory effect during the allergic response in the lung, and can be a promising treatment for allergic asthma in humans.
- Black Seed
- allergic asthma
- Th2-type cytokines mRNA
- mucin.
How to Cite
References
Lukacs NW, Miller AL, Hogaboam CM. Chemokine receptors in asthma: searching for the correct immune targets. The Journal of Immunology. 2003;171(1):11-5.
El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. International immunopharmacology. 2006;6(7):1135-42.
Wardlaw A, Dunnette S, Gleich GJ, Collins J, Kay A. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. American Review of Respiratory Disease. 1988;137(1):62-9.
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-78.
Abdel-Aziz M, Abass A, Zalata K, Al-Galel TA, Allam U, Karrouf G. Effect of dexamethasone and Nigella sativa on inducible nitric oxide synthase in the lungs of a murine model of allergic asthma. Iranian Journal of Allergy, Asthma and Immunology. 2014;13(5):324.
Ammar E-SM, Gameil NM, Shawky NM, Nader MA. Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. International immunopharmacology. 2011;11(12):2232-6.
Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB. Interleukins-4,-5, and-13: emerging therapeutic targets in allergic disease. Pharmacology & therapeutics. 2002;94(3):253-64.
Abbas AT, Abdel-Aziz MM, Zalata K, Abd A-GT-D. Effect of dexamethasone and Nigella sativa on peripheral blood eosinophil count, IgG1 and IgG2a, cytokine profiles and lung inflammation in murine model of allergic asthma. The Egyptian journal of immunology/Egyptian Association of Immunologists. 2004;12(1):95-102.
Gholamnezhad Z, Keyhanmanesh R, Boskabady MH. Anti-inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases: A review of basic and clinical evidence. Journal of Functional Foods. 2015;17:910-27.
Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacificjournal of tropical biomedicine. 2013;3(5):337-52.
Kalus U, Pruss A, Bystron J, Jurecka M, Smekalova A, Lichius JJ, et al. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytotherapy Research. 2003;17(10):1209-14.
Terzi A, Coban S, Yildiz F, Ates M, Bitiren M, Taskin A, et al. Protective effects of Nigella sativa on intestinal ischemia-reperfusion injury in rats. Journal of Investigative Surgery. 2010;23(1):21-7.
Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. International immunopharmacology. 2005;5(13):1749-70.
Boskabady M-H, Keyhanmanesh R, Khameneh S, Doostdar Y, Khakzad M-R. Potential immunomodulation effect of the extract of Nigella sativa on ovalbumin sensitized guinea pigs. Journal of Zhejiang University Science B. 2011;12(3):201-9.
Keyhanmanesh R, Boskabady MH, Khamneh S, Doostar Y. Effect of thymoquinone on the lung pathology and cytokine levels of ovalbumin-sensitized guinea pigs. Pharmacological reports. 2010;62(5):910-6.
Holtzman MJ, Byers DE, Alexander-Brett J, Wang X. The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nature Reviews Immunology. 2014;14(10):686-98.
Zuo L, He F, Sergakis GG, Koozehchian MS, Stimpfl JN, Rong Y, et al. Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2014;307(3):L205-L18.
Hossein BM, Nasim V, Sediqa A. The protective effect of nigella sativa on lung injury of sulfur mustard–exposed guinea pigs. Experimental lung research. 2008;34(4):183-94.
Kanter M, Coskun O, Budancamanak M. Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World journal of gastroenterology: WJG. 2005;11(42):6684-8.
Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD–implications and relevance for treatment. International journal of chronic obstructive pulmonary disease. 2014;9:1207.
El Mezayen R, El Gazzar M, Nicolls MR, Marecki JC, Dreskin SC, Nomiyama H. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunology letters. 2006;106(1):72-81.
Balaha MF, Tanaka H, Yamashita H, Rahman MNA, Inagaki N. Oral Nigella sativa oil ameliorates ovalbumin-induced bronchial asthma in mice. International immunopharmacology. 2012;14(2):224-31.
Blaeser F, Bryce PJ, Ho N, Raman V, Dedeoglu F, Donaldson DD, et al. Targeted inactivation of the IL-4 receptor α chain I4R motif promotes allergic airway inflammation. The Journal of experimental medicine. 2003;198(8):1189-200.
Renz H, Enssle K, Lauffer L, Kurrle R, Gelfand E. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. International archives of allergy and immunology. 1995;106(1):46-54.
Tanaka H, Kawada N, Yamada T, Kawada K, Takatsu K, Nagai H. Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor a chain-deficient mice. Clinical and Experimental Allergy. 2000;30(6):874-81.
Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258-61.
Komai M, Tanaka H, Masuda T, Nagao K, Ishizaki M, Sawada M, et al. Role of Th2 responses in the development of allergen‐induced airway remodelling in a murine model of allergic asthma. British journal of pharmacology. 2003;138(5):912-20.
Balaha M, Kandeel S, Tanaka H, Yamashita H, Abdel-Rahman MN, Inagaki N. Immunomodulatory effects of lovastatin on ovalbumin-induced bronchial asthma in mice. Journal of Experimental and Integrative Medicine. 2015;5(4):183-92.
El Gazzar M, El Mezayen R, Nicolls MR, Marecki JC, Dreskin SC. Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma. Biochimica et Biophysica Acta (BBA)-General Subjects. 2006;1760(7):1088-95.
Shahzad M, Yang X, Asim MR, Sun Q, Han Y, Zhang F, et al. Black seed oil ameliorates allergic airway inflammation by inhibiting T-cell proliferation in rats. Pulmonary pharmacology & therapeutics. 2009;22(1):37-43.
Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwarte LB, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. Journal of Allergy and Clinical Immunology. 1991;88(4):637-48.
Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. Journal of allergy and clinical immunology. 1997;99(4):539-44.
Durham S, Loegering D, Dunnette S, Gleich GJ, Kay A. Blood eosinophils and eosinophil-derived proteins in allergic asthma. Journal of allergy and clinical immunology. 1989;84(6):931-6.
Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, et al. Defective epithelial barrier function in asthma. Journal of Allergy and Clinical Immunology. 2011;128(3):549-56. e12.35. Kulshreshtha A, Ahmad T, Agrawal A, Ghosh B. Proinflammatory role of epithelial cell–derived exosomes in allergic airway inflammation. Journal of Allergy and Clinical Immunology. 2013;131(4):1194-203. e14.
Cohn L, Whittaker L, Niu N, Homer RJ, editors. Cytokine regulation of mucus production in a model of allergic asthma. Mucus Hypersecretion in Respiratory Disease: Novartis Foundation Symposium 248; 2002: Wiley Online Library.
Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nature medicine. 2002;8(8):885-9.
Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, Bottomly K. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. The Journal of Immunology. 1999;162(10):6178-83.
- Abstract Viewed: 660 times
- PDF Downloaded: 310 times